Search
Menu
Rocky Mountain Instruments - Infrared Optics LB

Candela Wins FDA Clearance for Psoriasis Device

Facebook X LinkedIn Email
WAYLAND, Mass., Jan. 30 -- Candela Corp. has received clearance from the US Food and Drug Administration to market a laser for the treatment of psoriasis. The company said it is conducting on-going clinical trials and expects to market the device this coming summer. Following acne, psoriasis is the second most common skin disorder in the United States, said Gerard E. Puorro, Candela's president and CEO. The market is underserved by current treatments. We are excited to be able to play a role in such a market.Read full article

Related content from Photonics Media

    Published: January 2001
    News & Features

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.